Stockreport

Abbott (ABT) Stock Rated Buy on Strong Diabetes Trial Results [Yahoo! Finance]

Abbott Laboratories  (ABT) 
Last abbott laboratories earnings: 4/16 07:30 am Check Earnings Report
US:NYSE Investor Relations: abbott.com/investors.html
PDF encouraging results from Abbott Laboratories (NYSE:ABT)'s FreeDM trial, Benchmark reiterated a Buy rating and $145 price target for the company's shares on March 13. In [Read more]